Accession Number: | 0001209191-23-010898 |
Date: | 2023-02-15 |
Issuer: | ICOSAVAX, INC. (ICVX) |
Original Submission Date: |
SIMPSON ADAM K.
C/O ICOSAVAX, INC.
1930 BOREN AVE., SUITE 1000
SEATTLE, WA 98101
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 9.06 | 2023-02-15 | deemed execution date | A | 350,000 (a) | 2033-02-14 | common stock 350,000 | $9.06 | 350,000 | direct |
ID | footnote |
---|---|
f1 | 25% of the shares subject to the option will vest on february 15, 2024, and 1/48th of the shares subject to the option vest monthly thereafter, subject to the reporting person's continued service through the applicable vesting date. |